Contact this trialFirst, we need to learn more about you.
BCL-2 Inhibitor
Venetoclax + Chemotherapy for Acute Lymphoblastic Leukemia
Recruiting1 awardPhase < 1
New York, New York
This trial is testing if adding venetoclax to standard chemotherapy is safe and effective for adults under 60 with newly diagnosed T- or B-cell acute lymphoblastic leukemia (ALL). Venetoclax helps chemotherapy work better by blocking a protein that keeps cancer cells alive. Venetoclax has shown promise in treating various forms of leukemia, including acute lymphoblastic leukemia (ALL), by enhancing the effectiveness of chemotherapy.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service